The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Rheumatology (Oxford). 2019 Feb 1;58(2):e3-e42. doi: 10.1093/rheumatology/key208.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Biological Products / adverse effects*
  • Biological Products / therapeutic use*
  • Comorbidity
  • Contraindications, Drug
  • Evidence-Based Medicine / methods
  • HIV Infections / complications
  • Heart Diseases / complications
  • Humans
  • Neoplasms / complications
  • Opportunistic Infections / complications
  • Patient Safety / standards
  • Respiration Disorders / complications
  • Tuberculosis / complications
  • Vaccination / adverse effects

Substances

  • Antirheumatic Agents
  • Biological Products